83 related articles for article (PubMed ID: 24912088)
1. Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology of Staphylococcus aureus Keratitis.
Caballero AR; Foletti DL; Bierdeman MA; Tang A; Arana AM; Hasa-Moreno A; Sangalang ERB; O'Callaghan RJ
Ocul Immunol Inflamm; 2015 Aug; 23(4):297-303. PubMed ID: 24912088
[TBL] [Abstract][Full Text] [Related]
2. Corneal pathogenesis of Staphylococcus aureus strain Newman.
Dajcs JJ; Austin MS; Sloop GD; Moreau JM; Hume EB; Thompson HW; McAleese FM; Foster TJ; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1109-15. PubMed ID: 11923253
[TBL] [Abstract][Full Text] [Related]
3. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Infect Immun; 1994 Jun; 62(6):2478-82. PubMed ID: 8188373
[TBL] [Abstract][Full Text] [Related]
4. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
[TBL] [Abstract][Full Text] [Related]
5. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.
Dajcs JJ; Thibodeaux BA; Girgis DO; O'Callaghan RJ
DNA Cell Biol; 2002; 21(5-6):375-82. PubMed ID: 12167239
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
[TBL] [Abstract][Full Text] [Related]
8. Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
O'Callaghan RJ; McCormick CC; Caballero AR; Marquart ME; Gatlin HP; Fratkin JD
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5125-31. PubMed ID: 17962465
[TBL] [Abstract][Full Text] [Related]
9. Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis.
Romanowski EG; Mah FS; Kowalski RP; Yates KA; Gordon YJ
J Ocul Pharmacol Ther; 2008 Aug; 24(4):380-4. PubMed ID: 18665809
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus corneal virulence in a new topical model of infection.
Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
12. Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus α-toxin.
Weeks AC; Balzli CL; Caballero A; Tang A; O'Callaghan R
Curr Eye Res; 2012 Feb; 37(2):87-93. PubMed ID: 22050601
[TBL] [Abstract][Full Text] [Related]
13. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
14. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
17. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
